Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Munch-a-Biotech Today -- Ignore unavailable to you. Want to Upgrade?

To: rkrw who wrote (2244)	10/18/2006 2:33:15 PM
From: nigel bates	Read Replies (2) \| Respond to of 3158

Interesting idea (:-)), but I should probably have added 'in the oncology space' ? Could MLNM afford anything as big as ITMN ? Would probably have to be for stock, and if that were the plan, why not merge with Exelixis ? EXEL provides the compounds & most of the management, MLNM the financial strength & salesforce... and a few more proprietory targets <g>. Plenty of room for cutting out duplicated costs ? Makes a lot of sense to me, but my job's not on the line.